COMPUTING THE FUTURE OF MEDICINE

Welcome to the Brand page for “COMPUTING THE FUTURE OF MEDICINE”, which is offered here for Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of rnai-based pharmaceuticals and medicines; custom manufacture of short interfering rna (sirna) medicines; custom manufacture of nucleic acid-based drugs (nabds) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger rna (mrna) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid;computer software; downloadable computer software; computer software for use in the field of pharmaceuticals, medicines and drug discovery; artificial intelligence and machine learning software; artificial intelligence and machine learning software for use in the field of pharmaceuticals, medicines and drug discovery; databases; electronic databases for use in the field of pharmaceuticals, medicines and drug discovery; computer platform software; computer software platforms; computer platform software platforms for use in the field of pharmaceuticals, medicines and drug discovery; computer software platforms for use in the field of pharmaceuticals, medicines and drug discovery;pharmaceutical and medical preparations; pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; rnai-based medicines and pharmaceuticals; short interfering rna (sirna) medicines and pharmaceuticals; nucleic acid-based drugs (nabds) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger rna (mrna) and triggering its degradation;scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to rnai-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering rna (sirna) medicines, nucleic acid-based drugs (nabds) for blocking gene expression, nucleic acid-based drugs (nabds) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mrna and triggering its degradation; drug discovery services; drug discovery services relating to rnai-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering rna (sirna) medicines, nucleic acid-based drugs (nabds) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mrna and triggering its degradation; genetic research; scientific and technical data analysis; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to rnai-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering rna (sirna) medicines, nucleic acid-based drugs (nabds) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mrna and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software; design, development, creation and maintenance of computational platforms; design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; platform as a service (paas); platform as a service (paas) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; platform as a service (paas) services relating to the use of artificial intelligence and machine learning software and databases in relation to rnai-based medicines and pharmaceuticals, short interfering rna (sirna) medicines, nucleic acid-based drugs (nabds) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mrna and triggering its degradation; design and development of computer-simulated models; design of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; non-downloadable computer software; non-downloadable computer software for use in the field of pharmaceuticals, medicines and drug discovery; software as a service (saas); software as a service (saas) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; software as a service (saas) services relating to the use of artificial intelligence and machine learning in relation to rnai-based medicines and pharmaceuticals, nucleic acid-based drugs (nabds) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mrna and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid;.

Its status is currently believed to be active. Its class is unavailable. “COMPUTING THE FUTURE OF MEDICINE” is believed to be currently owned by “E-Therapeutics Plc”.

Owner:
E-THERAPEUTICS PLC
Owner Details
Description:
Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid;Computer software; downloadable computer software; computer software for use in the field of pharmaceuticals, medicines and drug discovery; artificial intelligence and machine learning software; artificial intelligence and machine learning software for use in the field of pharmaceuticals, medicines and drug discovery; databases; electronic databases for use in the field of pharmaceuticals, medicines and drug discovery; computer platform software; computer software platforms; computer platform software platforms for use in the field of pharmaceuticals, medicines and drug discovery; computer software platforms for use in the field of pharmaceuticals, medicines and drug discovery;Pharmaceutical and medical preparations; pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals; short interfering RNA (siRNA) medicines and pharmaceuticals; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation;Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; genetic research; scientific and technical data analysis; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software; design, development, creation and maintenance of computational platforms; design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS); Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in relation to RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design and development of computer-simulated models; design of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; non-downloadable computer software; non-downloadable computer software for use in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS); Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning in relation to RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid;
Categories: CUSTOM MANUFACTURE PHARMACEUTICAL